Enlivex ENLV
NASDAQ ENLV
$1.47 -0.03 (-2.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Enlivex (ENLV) Other Accumulated Expenses (2017 - 2025)

Enlivex (ENLV) posted quarterly Other Accumulated Expenses of $1.9 million for Q4 2025, up 104.11% year-over-year from $925000.0 in Q4 2024, and up 163.69% quarter-over-quarter from $716000.0 in Q2 2025.

Enlivex (ENLV) Other Accumulated Expenses (2017 - 2025) Analysis & Trends

Enlivex's Other Accumulated Expenses history runs 9 years deep, the most recent figure standing at $1.9 million for Q4 2025.

  • In Q4 2025, Other Accumulated Expenses rose 104.11% year-over-year to $1.9 million; the TTM figure through Dec 2025 stood at $1.9 million (up 104.11% YoY), while the FY2025 annual figure was $1.9 million, up 104.11% from the prior year.
  • Other Accumulated Expenses for Q4 2025 stood at $1.9 million, up from $716000.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $2.7 million in Q4 2022, with the low at $716000.0 in Q2 2025.
  • The 5-year median for Other Accumulated Expenses is $1.7 million (2022), against an average of $1.7 million.
  • The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses tumbled 60.54% in 2024, then surged 104.11% in 2025.
  • Enlivex's Other Accumulated Expenses stood at $1.6 million in 2021, then soared by 65.53% to $2.7 million in 2022, then fell by 13.44% to $2.3 million in 2023, then sank by 60.54% to $925000.0 in 2024, then soared by 104.11% to $1.9 million in 2025.
  • Business Quant data shows ENLV's Other Accumulated Expenses at $1.9 million in Q4 2025, $716000.0 in Q2 2025, and $925000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Enlivex 4.51 Mn -1.25 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.89 Mn
Jun 30, 2025 716,000.00
Dec 31, 2024 925,000.00
Jun 30, 2024 1.60 Mn
Dec 31, 2023 2.34 Mn
Jun 30, 2023 1.70 Mn
Dec 31, 2022 2.71 Mn
Jun 30, 2022 1.64 Mn
Dec 31, 2021 1.64 Mn
Jun 30, 2021 2.08 Mn
Dec 31, 2020 1.50 Mn
Jun 30, 2020 1.32 Mn
Dec 31, 2019 1.55 Mn
Dec 31, 2018 575,000.00
Dec 31, 2017 157,000.00